2Pedersen T R, Kjeekshus J, Berg K, et al. Cholesrenrol lowering and the utillization of healthcare resouces:Results of the Scandinavian Simrastatin Survival Study (4S) . Circulation, 1996,93 (10) :1796.
3Deslypere JP , Delanghe J, Vermeulen A, et al. Proteinuria as complication of simvastatin treatment. Lancet,1990,336: 1453.
4Anonymous. Simvastatin and alopecia. Aust Adverse Drug React Bull, 1993, 12: 7.
5Duits N, Bos FM. Depressive symptoms and cholestrol lowering drugs. Lancet, 1993, 341: 114.
6Schaefer EJ. HMG-Co A reductase inhibitors for hypercholesterolemia. N Engl J Med, 1988, 319: 1222.
7Barth JD, Kruisbrink OA, Van Dijk AL, et al. Inhibitors of hydroxymethylylutaryl coenzyme A reductase for treating hypercholesterolaemia. Br Med J, 1990, 301: 669.
8Cauley JA, Cammings SR, Black DM, et al. Sleep distrubances and HMG-CoA reductase inhibitors. JAMA,1990, 264:1105.
9Eckernas S-A, Alran G, Paintaud G, et al. The effects of simvastatin and provastatin on objective and subjective measures of nocturnal sleep: a comparsion of two structurally different HMG-CoA reductase inhiobitors in patients with primary moderate hypercholesterolaemia. Br J Clin Pharmacol, 1993, 35: 284-9.
10Rosenson RS, Goranson NL. Lovastatin-associated sleep and mood disturbances. Am J Med, 1993, 95: 548-9.
6Ferdinand KC. The importance of aggressive lipid management in patients at risk:evidence from recent clinical trials [ J ]. Clin Cardiol, 2004; 27(6 Suppl. 3):S12- S15.
7Pastermask RC, SmithSC, Jr Bairey - mearz CN, et al. ACC/AHA/ NHLBI clinical advisory on the use and safety of statins[ J]. Circulation,2002; 106: 1024-1028.
8Ucar M, Mjomdal T, Dahlqviso R. HMGCOA reducl ase - in hibitor and myotoxicity [ J ]. Drug Safety,2000 ; 22 : 441 - 447.
9Silver MA, Langsjoen PH, Szabo S, et al. Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme QIO to reverse that dysfunction [ J ]. Am J Cardiol,2004 ; 94 : 1306 - 1310.
10Kostner K,Howes LG. Statins and monitoring of liver function tests[J]. Drug Safety, 2007,30 (1) : 1-4.
